Emotional Brain was originally founded by dr. Adriaan Tuiten, PhD, in 2001, for the purpose of engaging in fundamental and applied scientific research into biological, psychological and social mechanisms involved in the cognitive and social functioning or dysfunctioning of individuals, and the development of multi-agent systems.
While studying at University, with a focus on hormonal regulation of behavior, dr. Tuiten made an important discovery about the characteristics of one specific hormone. After he had founded Emotional Brain, knowing that his discovery could potentially benefit vast numbers of women suffering from Female Sexual Dysfunction (FSD), he decided to devote further research to FSD. In 2005 this resulted in the company’s current core business, the development of two new drugs for the treatment of FSD: Lybrido and Lybridos.
To date, we have conducted over 20 studies in approximately 1200 women as part of the Lybrido and Lybridos development program. Three Phase 2B studies have been conducted in the US (2011-2014) investigating the safety and efficacy of Lybrido and Lybridos in nearly 500 women with Hypoactive Sexual Desire Disorder.
Learn more about our collaboration with the Alan Turing Institute Almere, an institute which has its focus on the development of multi-agent systems.